Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
Go back to Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109| (NASDAQ: TVRD) | Delayed: 1.77 +0.01 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.76 | 52 Week High | $ | |||
| Open | $1.78 | 52 Week Low | $ | |||
| Day High | $1.82 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $ | |||
| Volume | 183,655 | |||||
